Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
Quick Stats
Jun 15, 202665.0
AI Score
BUY0.21
Volume Ratio
Aug 04, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
HRMY Stock Summary
Last updated Jun 15, 2026
HRMY is currently trading at $34.075, positioned above its 200-day moving average of $32.34, indicating a long-term uptrend. The stock has a 52-week range of $25.52 to $40.87.
Technical Analysis: The 50-day moving average stands at $31.12, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.598, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.157, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates HRMY at 65.0/100 with a BUY recommendation.
HRMY (Harmony Biosciences Holdings, Inc. Common Stock) Indicators
Last updated Jun 15, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 63.598 |
| CMF (20) | 0.157 |
| ROC (10) | 8.425 |
| ADX (14) | 22.049 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.086 |
| AROONOSC (14) | 85.714 |
| WILLAMS %R (14) | -25.172 |
| MFI (14) | 75.776 |
HRMY Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
HRMY Price vs Max Options Open Interest
HRMY Max Change In Options Open Interest
HRMY Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HRMY Daily Out of Money Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HRMY Daily In the Money Options - Sort by Max open Interest (near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
HRMY Most Active Options by Volume(near term)
15th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Harmony Biosciences Holdings, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
HRMY Moving Averages Analysis
Harmony Biosciences Holdings, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 15, 2026
Harmony Biosciences Holdings, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jun 15, 2026
HRMY (Harmony Biosciences Holdings, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Jun 15, 2026
| Days | MA |
|---|---|
| 10 | 33.43 |
| 20 | 32.12 |
| 30 | 31.82 |
| 50 | 31.12 |
| 100 | 31.32 |
| 200 | 32.34 |
HRMY Fundamental Analysis
| P/E (Forward) | 11.1607 |
| P/E (Trailing) | 14.1935 |
| Market Cap ($) | 2.0 billion |
| Earnings/Share ($) | 2.48 |
| Net Proft Margin (%) | 0.162 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 4.3931 |
| EPS Estimate Next Year ($) | 5.5815 |
| WallStreet Target Price ($) | 44.3636 |
| Most Recent Quarter |